Minerva Neurosciences (NERV) Reports Q3 Loss of $0.28
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Equities end higher as Anthropic's IPO filing buoys AI stocks
- Anthropic files for Nasdaq IPO as revenue jumps to $16.3 billion
- Meta reverses losses to rise as investors weigh $35 billion AI funding plan
- Post-election relief ahead for markets, says Morgan Stanley
- Musk says SpaceX raised $40 billion in debt, warns of neocloud collapse
Tweet
Share
E-mailGet Alerts NERV Hot Sheet
Join SI Premium – FREE
Minerva Neurosciences (NASDAQ: NERV) reported Q3 EPS of ($0.28), versus $0.00 reported last year. Revenue for the quarter came in at $0 , versus $0 reported last year.
For earnings history and earnings-related data on Minerva Neurosciences (NERV) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Herc Holdings (HRI) Tops Q3 EPS by 95c ; Offers Guidance
- AllianceBernstein (AB) Tops Q3 EPS by 2c
- CMS Energy (CMS) Tops Q3 EPS by 21c; offers guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
